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This book provides a very comprehensive overview of in vitro and
in vivo screening methodologies and toxicology, together with
clinical trials design. As a medicinal chemist who has encountered
many of the in vitro assays and some of the in vivo assays
described, this volume provides a fascinating rare, global view of
this vast subject.
The book is divided into four sections: in vitro methods, in vivo
methods, nonclinical testing (toxicology) and clinical testing.
Separate chapters with mostly different authors contribute to each
chapter. A welcome feature is the supply of an e-book with the
printed volume, especially useful given the size and weight of the
conventional volume. Two IT personnel, 1h, a new copy of
Acrobat reader 6 and the e-book sat easy to access on my laptop.
Simple search functions are available in this program, but no
Boolean logic with the free version. The general presentation of the
book is poor, with the figures probably published as presented by
the authors. There is no use of colour at all, sorely missed in those
sections including histology. There is no glossary, a key omission if
the book is intended for a wider audience. Fortunately, there is an
index. The book has the feel of a conference proceedings rather
than a quality textbook or monograph.
These misgivings aside, the volume is bursting with useful
information for the career professional and the interested scientist.
For such a comprehensive treatise, I can only select a few
highlights. Chapter 2 on high-throughput screening contributed by
Bioclair and colleagues is an easy-to-follow guide to the latest state
of the art in this area. Chapter 6 on the use of solid tumour model
in rodents for tumour screening by Corbett and colleagues was for
me the highlight of the book, providing an exceptionally clear and
well-written guide to this vital area. The examples on how to
conduct an in vivo assay (and more to the point how not to)
should be required for reading for professionals in this area.
However, there are many other highlights: Chapter 9 on orthotopic
metastatic models, Chapter 12 on the use of companion animals
for tumour screening is an eye opener. The vast number of such
animals and their caring owners will likely provide a useful
resource for evaluation of novel therapies in the future.
In the pre-clinical and clinical trials sections, the book switches
from a review format to be more of a professional guide. Detailed
descriptions of NDA and NCI requirements and panels are
provided and these will prove useful to the specialist. There is
also a chapter on the different scenario for clinical testing in
Europe. I found Section III on nonclinical testing (toxicological
testing) the best organised of the book. Perhaps this is to be
expected as it was written by a small number of authors (Roy,
Andrews and Laurencot). These authors cover the different aspects
of planning and conducting toxicology studies for both small
molecules and biologics. The authors make a key point with
relevance to clinical testing of a combination of drugs, namely that
the potential adverse synergistic effects must be considered in
addition to the potential benefits.
The one aspect I missed overall was a forward-looking chapter
from each section. What are the key problems with in vitro and in
vivo methods? What avenues are being explored to overcome these
problems? Also are biologics dealt with in sufficient detail in the
book, what special problems do they present for the development
process? These gripes aside, I feel I will be consulting this volume
for years to come when I require information about a specific
aspect of the anti-cancer drug development process.
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